can tirzepatide cause kidney damage The promise of tirzepatide: A narrative review of metabolic benefits Diabetic kidney disease: Part 2

Gastric bypass patients asking about GLP-1 therapy need specialized guidance

Drug exposure is largely independent of injection site, as well as age, race and ethnicity

and Novo Nordisk A/S were sued Wednesday by a top compounding pharmacy that makes copycat versions of their blockbuster obesity and diabetes drugs.

Cardiovascular Business is an independent news site that reports on cardiovascular health and medicine for an audience of healthcare and medical professionals

Discover why this combination lacks regulatory approval, the safety risks involved, and evidence-based alternatives recommended by UK clinical guidelines.